Q3 2023 Relmada Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Relmada Therapeutics, Inc. third quarter 2023 earnings conference call. (Operator Instructions) This call is being recorded on Wednesday, November 8, 2023.
I would now like to turn the conference over to Tim McCarthy of LifeSci Advisors. Please go ahead.
Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa; and Chief Financial Officer, Maged Shenouda; and Dr. Cedric O'Gorman, Chief Medical Officer. This afternoon, Relmada issued a press release providing a business update announcing financial results for the 3 and 9 months ended September 30, 2023.
Please note that certain information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that during this call, Relmada's management team will be making forward-looking statements. Actual results
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |